MoFo Life Sciences

May 22, 2020 - COVID-19, CFIUS, Healthcare, Asia
Japan Moves to Tighten Restrictions on Foreign Investment in Healthcare Industries
By: Gary Mitchel Smith
Amid concerns about predatory acquisitions of weakened companies and strategic assets during the COVID‑19 crisis, more and more countries are restricting foreign direct investment (FDI) in their domestic companies, especially in the medical and healthcare industries. These restrictions tend to target Chinese investment in
... ›
May 04, 2020 - United States, CFIUS
CFIUS Filing Fees Become Reality
By: Charles L. Capito, Joseph A. Benkert and Jonathan M. Babcock
The U.S. Department of the Treasury announced that on Friday, May 1, 2020, the first-ever filing fees will become effective for joint voluntary notices submitted to the Committee on Foreign Investment in the United States (CFIUS). Notices submitted to CFIUS on or after May
... ›
October 15, 2019 - United States, CFIUS, Regulatory
Foreign Investment 2020: CFIUS Spotlight on “TID” U.S. Businesses
By: Charles L. Capito and Joseph A. Benkert
FIRRMA directed the U.S. Department of the Treasury (“Treasury”), as the chair of CFIUS, to issue regulations that, among other things, address national security concerns arising from foreign investment in U.S. businesses with critical technologies, critical infrastructure, and personal data (referred to in the
... ›
September 25, 2019 - United States, CFIUS, Regulatory
Foreign Investment 2020: Key Takeaways from the “Modernized” CFIUS Regulations
By: Joseph A. Benkert and Charles L. Capito
After more than a year of anticipation, the U.S. Department of the Treasury (“Treasury”) has released proposed regulations to implement the Foreign Investment Risk Review Modernization Act (FIRRMA). These proposed regulations follow an initial round of FIRRMA-implementing regulations issued in October 2018, which most notably included
... ›
October 30, 2018 - United States, Biotech, CFIUS, Pharma, Regulatory
New CFIUS Pilot Program: What Life Sciences Companies and Investors Need to Know
By: Robert S. Litt and Joseph A. Benkert
As many life sciences companies and investors are aware, the U.S. Department of the Treasury (“Treasury”) recently announced a new “pilot program” for the Committee on Foreign Investment in the United States (“CFIUS”) effective November 10, 2018. The pilot program implements certain provisions of
... ›

Topic Archives: CFIUS

Japan Moves to Tighten Restrictions on Foreign Investment in Healthcare Industries

By: Gary Mitchel Smith

CFIUS Filing Fees Become Reality

By: Charles L. Capito, Joseph A. Benkert and Jonathan M. Babcock

Foreign Investment 2020: CFIUS Spotlight on “TID” U.S. Businesses

By: Charles L. Capito and Joseph A. Benkert

Foreign Investment 2020: Key Takeaways from the “Modernized” CFIUS Regulations

By: Joseph A. Benkert and Charles L. Capito

New CFIUS Pilot Program: What Life Sciences Companies and Investors Need to Know

By: Robert S. Litt and Joseph A. Benkert